Kangpu Biopharmaceuticals Ltd.
๐จ๐ณChina
- Country
- ๐จ๐ณChina
- Ownership
- Holding
- Established
- 2011-01-19
- Employees
- 11
- Market Cap
- -
- Website
- https://www.kangpugroup.com
Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in SLE
Phase 1
Completed
- Conditions
- SLE; Drug
- Interventions
- Drug: KPG-818 mid doseDrug: KPG-818 low doseDrug: KPG-818 high doseDrug: Placebo
- First Posted Date
- 2020-11-24
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- Kangpu Biopharmaceuticals, Ltd.
- Target Recruit Count
- 64
- Registration Number
- NCT04643067
- Locations
- ๐บ๐ธ
Anniston Medical Clinic, Anniston, Alabama, United States
๐บ๐ธHope Clinical Trials, Inc., Coral Gables, Florida, United States
๐บ๐ธSTAT Research, Vandalia, Ohio, United States
Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects
- First Posted Date
- 2020-02-25
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Kangpu Biopharmaceuticals, Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT04283097
- Locations
- ๐บ๐ธ
UC Davis Comprehensive Cancer Center, Sacramento, California, United States
๐บ๐ธBRCR Global - USA, Plantation, Florida, United States
๐บ๐ธNorton Cancer Institute, Louisville, Kentucky, United States
Safety, Tolerability and Pharmacokinetics of KPG-818 in Healthy Subjects
- First Posted Date
- 2019-05-14
- Last Posted Date
- 2020-02-25
- Lead Sponsor
- Kangpu Biopharmaceuticals, Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT03949426
- Locations
- ๐บ๐ธ
California Clinical Trials Medical Group, Glendale, California, United States
Evaluation of Safety and Efficacy of KPG-121 Plus Enzalutamide, Abiraterone or Apalutamide in CRPC Patients
Phase 1
Completed
- Conditions
- Castration-Resistant Prostate Cancer
- Interventions
- Combination Product: Enzalutamide or Abiraterone or Apalutamid
- First Posted Date
- 2018-06-26
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Kangpu Biopharmaceuticals, Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT03569280
- Locations
- ๐บ๐ธ
University of Virginia Cancer Center, Charlottesville, Virginia, United States
๐บ๐ธComprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States
๐บ๐ธNorth Shore Hematology Oncology Associates DBA NY Cancer and Blood Specialists, Port Jefferson Station, New York, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath